Sangeeta N. Bhatia - Jul 29, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Joy Liu, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Jul 29, 2022
Transactions value $
-$173,116
Form type
4
Date filed
8/2/2022, 04:16 PM
Previous filing
May 4, 2022
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale -$27.4K -99 -1.68% $276.65 5.8K Jul 29, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$55.6K -200 -3.45% $277.95 5.6K Jul 29, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$44.7K -160 -2.86% $279.28 5.44K Jul 29, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$27.7K -99 -1.82% $280.22 5.35K Jul 29, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$16.3K -58 -1.09% $281.03 5.29K Jul 29, 2022 Direct F1, F2, F7
transaction VRTX Common Stock Sale -$1.41K -5 -0.09% $282.34 5.28K Jul 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
F2 Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $276.65 (range $276.21 to $276.83).
F4 Open market sales reported on this line occurred at a weighted average price of $277.95 (range $277.63 to $278.35).
F5 Open market sales reported on this line occurred at a weighted average price of $279.28 (range $278.86 to $279.83).
F6 Open market sales reported on this line occurred at a weighted average price of $280.22 (range $279.88 to $280.78).
F7 Open market sales reported on this line occurred at a weighted average price of $281.03 (range $280.93 to $281.08).